Sarissa Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-1,000
| Closed | -$161K | – | 12 |
|
2021
Q2 | $161K | Hold |
1,000
| – | – | 0.01% | 13 |
|
2021
Q1 | $171K | Hold |
1,000
| – | – | 0.02% | 12 |
|
2020
Q4 | $219K | Hold |
1,000
| – | – | 0.02% | 11 |
|
2020
Q3 | $166K | Hold |
1,000
| – | – | 0.02% | 11 |
|
2020
Q2 | $114K | Hold |
1,000
| – | – | 0.01% | 12 |
|
2020
Q1 | $76K | Hold |
1,000
| – | – | 0.01% | 12 |
|
2019
Q4 | $128K | Hold |
1,000
| – | – | 0.01% | 12 |
|
2019
Q3 | $77K | Hold |
1,000
| – | – | 0.01% | 11 |
|
2019
Q2 | $103K | Hold |
1,000
| – | – | 0.01% | 12 |
|
2019
Q1 | $73K | Hold |
1,000
| – | – | 0.01% | 11 |
|
2018
Q4 | $42K | Buy |
+1,000
| New | +$42K | 0.01% | 10 |
|